← Case Library

Clause 7.9

⚖ 31 PMCPA cases 🔒 Members see all 31 cases

PMCPA Cases — Clause 7.9

31 cases
📅 8 Mar 2026 · AstraZeneca

AstraZeneca voluntary admission: uncertified Crestor promotional email with misleading dosing and comparative claims

Clause 14.1 Clause 3.2 Clause 4.1 Clause 7.10 +4 more
📅 8 Mar 2026 · Boehringer Ingelheim

AUTH/2260/9/09: Boehringer Ingelheim rep emailed misleading/disparaging claims about Xarelto (rivaroxaban)

Clause 15.2 Clause 7.2 Clause 7.4 Clause 7.9 +2 more
📅 8 Mar 2026 · AstraZeneca

AstraZeneca: Seroquel ad claim of “favourable weight profile” ruled misleading (AUTH/2294/1/10, AUTH/2296/1/10, AUTH/2297/1/10)

Clause 7.2 Clause 7.4 Clause 7.9 Clause 9.1
🔒

See all 31 cases for Clause 7.9

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

Already a member? Sign in

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free